Cirrhosis of Liver in Ayurveda: A Critical Review of Kumbha Kamala and Yakritodara with Emphasis on Tridoshic Management—Bridging Classical Wisdom and Modern Science

 Corresponding author: Dr. Pardeep Kumar Sharma M.D. (Ayu) Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. Cirrhosis of Liver in Ayurveda: A Critical Review of Kumbha Kamala and Yakritodara with Emphasis on Tridoshic Management—Bridging Classical Wisdom and Modern Science Pardeep Kumar Sharma 1, , Neetu Sharma 2 and Rajendar Yadav 3 1 Medical Director and Consultant, Sukhayu Ayurved, Jaipur, Rajasthan, India. 2 Chief Medical Officer cum Consultant, Sukhayu Ayurved, Jaipur, Rajasthan, India. 3 Resident Medical Officer, Sukhayu Ayurved, Jaipur, Rajasthan, India. World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 Publication history: Received on 02 August 2025; revised on 07 September 2025; accepted on 09 September 2025 Article DOI: https://doi.org/10.30574/wjarr.2025.27.3.3183 Abstract Background: Cirrhosis of the liver is a progressive, irreversible condition with major clinical and social impact. While commonly correlated with Pitta in Ayurveda due to the liver's metabolic and Ranjaka Pitta functions, this review critically examines classical descriptions and modern hepatology to demonstrate that Vata and Kapha are equally involved, especially in chronic, decompensated cases. Objective: To establish the textual and clinical equivalence of cirrhosis with Kumbha Kamala, Yakritodara, and Jalodara in Ayurveda, and to highlight the necessity of a tridoshic diagnostic and therapeutic approach. Methods: A selective review of Charaka, Sushruta, Ashtanga Hridaya, Madhava Nidana, and standard hepatology literature was conducted. Clinical features, pathophysiology, and dosha-dhatu involvement were mapped in both systems, with attention to differential diagnosis and therapeutic implications. Results: Cirrhosis closely parallels Kumbha Kamala and Yakritodara in classical texts. These conditions arise from initial Pitta derangement (inflammation, jaundice), progress with Vata involvement (fibrosis, ascites, degeneration), and culminate in Kapha manifestations (fluid retention, congestion). Clinical signs such as persistent jaundice, ascites, hepatosplenomegaly, variceal bleeding, and cachexia match classical descriptions. Focusing only on Pitta results in incomplete management; tridoshic assessment and individualized therapy are essential. Conclusion: Classical Ayurvedic texts and modern hepatology both support a tridoshic understanding of cirrhosis. Comprehensive management addressing Pitta, Vata, and Kapha imbalances is required for optimal patient outcomes. Keywords: Cirrhosis; Kumbha Kamala; Yakritodara; Jalodara; Tridosha; Ayurveda; Liver; Portal Hypertension; Ascites; Integrative Medicine 1. Introduction Cirrhosis of the liver represents a chronic, end-stage hepatic disorder characterized by irreversible fibrosis, regenerative nodule formation, and distortion of normal hepatic architecture, ultimately leading to progressive hepatic insufficiency and portal hypertension [1,2]. In contemporary clinical practice, cirrhosis presents with a constellation of symptoms including jaundice, ascites, hepatosplenomegaly, varices, and progressive cachexia, and remains a leading cause of morbidity and mortality worldwide [1,3]. World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 597 In Ayurveda, while the Yakrit (liver) is primarily considered a seat of Pitta—specifically, Ranjaka Pitta, which is responsible for blood metabolism and coloration—complex hepatic diseases cannot be fully explained by Pitta alone. A reductionist approach often equates all liver disorders with Pitta imbalance, but classical texts and clinical observation reveal a dynamic interplay of all three doshas [4,5]. This review aims to critically appraise the Ayurvedic correlates of cirrhosis, highlight the shortcomings of Pitta-only thinking, and advocate for a tridoshic management strategy through direct textual and clinical mapping. The significance of this review lies in its potential to bridge the gap between traditional Ayurvedic understanding and modern hepatological knowledge, providing a more comprehensive framework for understanding and treating liver cirrhosis. By examining the classical descriptions of Kumbha Kamala and Yakritodara alongside contemporary understanding of cirrhosis pathophysiology, we can develop more effective integrative treatment approaches that honor both systems of medicine. 2. Methods This review utilized selective textual analysis of primary Ayurvedic treatises—Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, and Madhava Nidana—alongside secondary modern hepatology sources including Robbins & Cotran, Cecil Medicine, and Lancet reviews. Features of cirrhosis were systematically mapped to Ayurvedic entities based on dosha, dhatu, and srotas involvement, clinical features, and prognosis. Differential diagnoses and treatment implications were also comprehensively assessed. The methodology involved a comparative analysis approach, wherein classical Sanskrit texts were examined for descriptions of liver-related disorders, their etiology, pathogenesis, clinical manifestations, and therapeutic approaches. These findings were then correlated with modern understanding of cirrhosis pathophysiology, clinical presentation, and management strategies. Special attention was paid to the progression of disease from acute to chronic stages and the involvement of multiple doshas in advanced disease states. 3. Ayurvedic Understanding of Liver Disorders 3.1. Liver in Ayurveda: Yakrit and Ranjaka Pitta The Yakrit (liver) is identified as the root of the Raktavaha Srotas and the principal site of Ranjaka Pitta, which transforms plasma (Rasa) into blood (Rakta) [4]. Classical texts describe the liver's multifaceted role in metabolism, blood formation, and storage functions [5]. Disruption in Yakrit function due to doshic imbalance, dietary errors, or the accumulation of toxins (ama) results in a spectrum of hepatic disorders ranging from mild functional disturbances to severe structural damage. The liver's central role in Ayurvedic physiology extends beyond simple Pitta functions. It serves as a crucial metabolic hub where the transformation of nutrients occurs, where waste products are processed, and where the delicate balance of bodily humors is maintained. The Yakrit is intimately connected with Agni (digestive fire), and its proper functioning is essential for maintaining overall health and vitality. 3.2. Kamala and Kumbha Kamala Kamala represents the archetypal jaundice syndrome, characterized by yellow discoloration of skin and eyes, dark urine, poor appetite, and weakness—primarily resulting from Pitta vitiation affecting Ranjaka Pitta in the Yakrit [4,6]. This condition typically manifests in acute hepatic disorders where inflammation and metabolic dysfunction predominate. When Kamala is neglected, persists, or is improperly managed, it progresses to Kumbha Kamala—a chronic condition characterized by persistent jaundice, massive abdominal distension (ascites), profound weakness, and often a poor prognosis. The term "kumbha" refers to a pitcher, vividly describing the fluid-filled, distended abdomen that characterizes this advanced stage [6,7]. This progression from acute to chronic disease reflects the natural history of many liver disorders, including viral hepatitis progressing to cirrhosis. The classical description of Kumbha Kamala includes several key features that align remarkably with modern understanding of decompensated cirrhosis. These include not only the obvious ascites and jaundice but also the systemic manifestations such as muscle wasting, fatigue, and the development of collateral circulation. The texts World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 598 describe how the condition becomes increasingly difficult to treat as it progresses, reflecting the irreversible nature of advanced liver disease. 3.3. Udara Roga: Yakritodara and Jalodara Udara Roga encompasses eight distinct types of abdominal distension and ascites as described in Sushruta Samhita, with Yakritodara (liver-induced ascites) and Jalodara (ascites of all causes) being most relevant to cirrhosis [8,9]. Yakritodara specifically features a firm, enlarged liver, pronounced ascites, loss of appetite, visible abdominal veins (suggesting portal hypertension), and progressive limb wasting. Jalodara describes general fluid accumulation regardless of etiology, though hepatic causes are recognized as predominant [9]. The detailed descriptions of Yakritodara in classical texts reveal a sophisticated understanding of liver disease complications. The mention of visible abdominal veins clearly corresponds to the development of portosystemic collaterals seen in portal hypertension. The combination of hepatomegaly, ascites, and systemic symptoms described in these texts provides a remarkably accurate clinical picture of what we now recognize as cirrhosis with portal hypertension. The progression from localized liver dysfunction to systemic complications involving fluid balance, circulation, and nutrition reflects the classical understanding that liver disease affects multiple body systems. This holistic view aligns well with modern recognition that cirrhosis is a systemic disease with multiorgan involvement. 3.4. Modern Medical Perspective on Cirrhosis Cirrhosis results from chronic hepatic injury caused by various factors including viral hepatitis, alcohol abuse, nonalcoholic fatty liver disease (NAFLD), and other hepatotoxic agents, ultimately progressing to widespread fibrosis and architectural distortion [1]. The pathophysiology involves repeated cycles of hepatocyte injury, inflammation, and repair, leading to excessive collagen deposition and the formation of regenerative nodules surrounded by fibrous septa. Clinical features of cirrhosis include jaundice due to impaired bilirubin metabolism, portal hypertension manifesting as ascites, varices, and splenomegaly, progressive muscle wasting due to metabolic dysfunction, and hepatic encephalopathy resulting from the accumulation of neurotoxic substances [1,2,3]. Management requires a multifaceted approach addressing inflammation, fibrosis progression, complications of portal hypertension, and nutritional and metabolic deficits. The modern understanding of cirrhosis pathophysiology reveals a complex interplay of inflammatory, fibrotic, and vascular processes. Initial hepatocyte injury triggers inflammatory cascades involving Kupffer cells, stellate cells, and various cytokines. Chronic inflammation leads to stellate cell activation and excessive collagen production, resulting in progressive fibrosis. Simultaneously, architectural distortion and increased intrahepatic resistance lead to portal hypertension and its associated complications. The systemic nature of cirrhosis becomes evident in advanced stages, with complications affecting cardiovascular, renal, pulmonary, and neurological systems. This systemic involvement reflects the liver's central role in metabolism, detoxification, and homeostasis, and explains why liver failure has such profound effects on overall health. 4. Pathophysiological and Clinical Correlation The mapping of cirrhosis and its Ayurvedic correlates reveals striking similarities in clinical presentation and disease progression, as summarized in the following comprehensive analysis. The correlation between modern and Ayurvedic understanding becomes even more apparent when examining the temporal progression of disease. Cirrhosis often begins as a predominantly Pitta disorder characterized by inflammation and metabolic dysfunction. However, with chronicity, Vata involvement becomes prominent through fibrosis formation, altered hepatic blood flow, and progressive tissue degeneration. Finally, Kapha manifestations dominate in advanced stages with fluid retention, congestion, and sluggish metabolism [4,6,8]. This tridoshic progression precisely matches the evolution seen in advanced Kamala progressing to Kumbha Kamala and various forms of Udara Roga. The pathophysiological correlation extends beyond mere symptom matching. The Ayurvedic concept of Ama (toxins) accumulation aligns with modern understanding of hepatotoxic damage and the liver's role in detoxification. The classical description of Agni (digestive fire) dysfunction corresponds to metabolic impairment seen in cirrhosis. The World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 599 involvement of multiple Srotas (channels) reflects the systemic nature of advanced liver disease affecting circulation, nutrition, and waste elimination. Table 1 Comparative Features: Cirrhosis and Ayurvedic Syndromes Clinical Feature Cirrhosis (Modern) Ayurveda Correlate Dosha/Dhatu Involvement Jaundice Bilirubin buildup, yellow skin/eyes Kamala, Kumbha Kamala Pitta (Ranjaka), Rakta Ascites Fluid in abdomen (portal HTN) Jalodara, Kumbha Kamala Vata (flow), Kapha (fluid), Rasa Hepatomegaly Enlarged, firm liver Yakritodara Pitta, Rakta, Meda Splenomegaly Portal hypertension Plihodara Rakta, Kapha Varices/Bleeding Collaterals, GI bleeding Raktapitta (complication) Pitta, Rakta, Srotas blockage Fatigue/Wasting Cachexia, muscle loss Daurbalya, Aruci Vata, Agni, Dhatu kshaya Encephalopathy Toxin buildup, confusion (Implicit in texts) Vata, Ama, Manovaha Srotas 4.1. The Pitfall of "Pitta Only" Thinking A major clinical error in Ayurvedic practice is treating cirrhosis as exclusively a Pitta disorder. While initial hepatic inflammation is indeed Pitta-mediated, chronicity inevitably brings Vata-driven fibrosis and degeneration, as well as Kapha-type fluid retention and metabolic sluggishness [4,7,8]. This oversimplified approach fails to address the complex, multisystem nature of advanced liver disease. Pitta-pacifying therapy alone may provide temporary relief from jaundice and inflammation but cannot reverse established fibrosis or resolve ascites. The exclusive use of cooling, bitter herbs and Pitta-reducing procedures may actually worsen the condition in advanced stages by further depleting already compromised digestive fire and failing to address the underlying structural changes in the liver. The consequences of this reductionist approach are significant. Patients may experience initial improvement in symptoms like jaundice and abdominal discomfort, leading to false confidence in the treatment approach. However, the underlying disease process continues to progress, and complications such as ascites, variceal bleeding, and encephalopathy may develop despite ongoing Pitta-focused treatment. Only a comprehensive tridoshic management approach—systematically reducing Pitta inflammation, supporting and regulating Agni, modulating Vata to address fibrosis and circulation, and managing Kapha to resolve fluid retention and congestion—can address the full spectrum of disease manifestations and provide optimal therapeutic outcomes. 4.2. Tridoshic Approach: Therapeutic Rationale Classical texts provide detailed guidance for managing complex liver disorders through a tridoshic approach: Pitta Management: This forms the foundation of treatment, particularly in early stages and during acute exacerbations. Cooling and hepatoprotective herbs such as Bhumi Amalaki (Phyllanthus niruri), Katuki (Picrorhiza kurroa), and Guduchi (Tinospora cordifolia) help reduce inflammation and protect hepatocytes. Virechana (therapeutic purgation) helps eliminate excess Pitta and accumulated toxins. Dietary regulation emphasizing cooling, easily digestible foods supports liver recovery [4,5,6]. Vata Management: Essential in chronic cases with fibrosis and ascites, Vata management involves nourishing and unctuous therapies to counter tissue degeneration. Anti-fibrotic herbs and formulations help prevent further scarring. Oil-based Bastis (medicated enemas) provide deep nourishment and help regulate Vata functions. Gentle, nourishing foods and lifestyle modifications support tissue regeneration [7,8]. Kapha Management: Critical for addressing fluid retention and metabolic sluggishness, Kapha management employs diuretic herbs like Punarnava (Boerhavia diffusa) and Gokshura (Tribulus terrestris). Channel-clearing herbs help World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 600 improve circulation and reduce congestion. Specific Panchakarma procedures help eliminate excess Kapha and restore proper fluid balance [8,9]. A comprehensive treatment protocol integrates dietary regimens tailored to individual constitution and disease stage, appropriate Panchakarma procedures (especially Basti and Virechana), hepatoprotective Rasayana therapy for tissue regeneration, and supportive therapies addressing all three doshas simultaneously. Modern research into Ayurvedic herbs supports their multifaceted actions, including hepatoprotection, anti-inflammatory, anti-fibrotic, and diuretic properties [10]. The timing and sequencing of treatments are crucial in tridoshic management. Initial focus on Pitta pacification helps control active inflammation and prevent further damage. As the acute phase subsides, emphasis shifts to Vata management to address structural changes and support regeneration. Throughout the treatment process, appropriate Kapha management prevents complications and maintains proper fluid balance. 4.3. Differential Diagnosis Accurate differential diagnosis is essential for appropriate treatment selection and prognosis: • Pandu (Anemia): Primarily characterized by pallor and weakness, Pandu may present with mild jaundice in severe cases but lacks the massive ascites, hepatosplenomegaly, and portal hypertension characteristic of cirrhosis [4,5]. The absence of significant abdominal distension and liver enlargement helps distinguish Pandu from advanced liver disease. • Raktapitta (Bleeding Disorders): This category describes various hemorrhagic syndromes and becomes relevant primarily when acute variceal bleeding complicates cirrhosis. However, Raktapitta lacks the chronic, progressive nature and structural liver changes seen in cirrhosis [5,8]. • Gulma (Abdominal Masses): While Gulma may present with abdominal enlargement, it typically involves discrete masses rather than the diffuse ascites and organomegaly of cirrhosis. The absence of jaundice and portal hypertension signs helps differentiate Gulma from liver disease [11]. • Yakshma (Consumptive Diseases): Advanced cirrhosis may resemble Yakshma due to progressive wasting and weakness. However, the specific hepatic manifestations, ascites, and portal hypertension of cirrhosis distinguish it from other consumptive disorders [11]. The differential diagnosis process in Ayurveda involves careful assessment of Prakriti (constitution), Vikriti (current imbalance), disease progression, and response to treatment. The presence of specific combinations of symptoms, particularly the triad of jaundice, ascites, and hepatomegaly, strongly suggests liver-related Udara Roga rather than other conditions. 5. Clinical Assessment and Prognosis Classical texts provide detailed guidance on assessing disease severity and prognosis in liver disorders. The presence of certain symptoms indicates advanced disease with poor prognosis, while others suggest potential for recovery with appropriate treatment. 5.1. Favorable Prognostic Indicators: • Recent onset of symptoms • Good appetite and digestion • Absence of severe ascites • Responsive to initial treatment • Strong constitution (Prakriti) 5.2. Unfavorable Prognostic Indicators: • Chronic, persistent symptoms • Severe ascites with rapid reaccumulation • Complete loss of appetite • Extreme weakness and wasting • Development of bleeding complications • Mental confusion or altered consciousness World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 601 The classical assessment methods align remarkably well with modern prognostic scoring systems like the Child-Pugh classification and MELD score, which consider similar parameters including ascites, encephalopathy, nutritional status, and laboratory markers of liver function. 5.3. Integration with Modern Management The integration of Ayurvedic principles with modern hepatology offers significant potential for improved patient outcomes. While modern medicine excels in acute management, complication prevention, and liver transplantation, Ayurveda provides valuable insights into constitutional assessment, individualized treatment, and supportive care. 5.4. Complementary Approaches: • Ayurvedic hepatoprotective herbs as adjuncts to standard medical therapy • Panchakarma procedures for detoxification and symptom management • Dietary and lifestyle modifications based on individual constitution • Stress management and yoga therapy for overall well-being • Rasayana therapy for supporting liver regeneration and immune function 5.5. Areas for Research: • Clinical trials of specific Ayurvedic formulations in cirrhosis management • Mechanistic studies of anti-fibrotic properties of classical herbs • Development of standardized protocols for integrative care • Long-term outcomes of combined Ayurvedic-modern treatment approaches The integration requires careful consideration of drug interactions, appropriate timing of interventions, and clear communication between practitioners of both systems. Patient safety must remain paramount, with regular monitoring of liver function and disease progression. 5.6. Future Directions and Research Opportunities The correlation between classical Ayurvedic descriptions and modern understanding of cirrhosis opens numerous avenues for research and clinical development: • Mechanistic Research: Investigation of the molecular mechanisms underlying the anti-fibrotic, hepatoprotective, and regenerative properties of classical Ayurvedic herbs and formulations. Understanding how these substances modulate stellate cell activation, inflammatory pathways, and tissue repair processes could lead to new therapeutic targets. • Clinical Studies: Well-designed randomized controlled trials comparing tridoshic Ayurvedic management with standard care, or evaluating Ayurvedic treatments as adjuncts to conventional therapy. Such studies should include appropriate outcome measures, long-term follow-up, and safety assessments. • Personalized Medicine: Development of methods to correlate Ayurvedic constitutional assessment (Prakriti) with genetic markers, metabolic profiles, and treatment response patterns. This could lead to more precise, individualized treatment approaches. • Preventive Strategies: Investigation of Ayurvedic approaches to preventing progression from early liver disease to cirrhosis, particularly in high-risk populations. This could include dietary interventions, lifestyle modifications, and specific herbal protocols. • Quality of Life: Assessment of how tridoshic management affects patient-reported outcomes, functional status, and overall quality of life compared to conventional care alone. 5.7. Limitations and Considerations While this review presents compelling correlations between Ayurvedic and modern understanding of cirrhosis, several limitations must be acknowledged: • Textual Interpretation: Classical Sanskrit texts may be subject to varying interpretations, and the correlation with modern disease entities requires careful scholarly analysis. Different commentaries and translations may yield slightly different understandings of specific conditions. • Clinical Validation: While the theoretical correlations are strong, extensive clinical validation through rigorous research is needed to confirm the effectiveness of tridoshic approaches in managing cirrhosis. World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 602 • Standardization: Ayurvedic treatments often require individualization based on constitution and specific imbalances, making standardization for research purposes challenging. • Safety Considerations: Some Ayurvedic treatments, particularly Panchakarma procedures, may not be appropriate for patients with advanced liver disease and portal hypertension. Careful assessment and modification of traditional protocols may be necessary. • Integration Challenges: Combining Ayurvedic and modern approaches requires careful coordination to avoid adverse interactions and ensure optimal timing of interventions. 6. Conclusion This comprehensive review demonstrates that cirrhosis of the liver in Ayurveda is most accurately understood as Kumbha Kamala or Yakritodara—both representing chronic, tridoshic disorders involving complex interactions between Pitta, Vata, and Kapha in their pathogenesis and clinical evolution. The classical descriptions in Ayurvedic texts show remarkable correlation with modern understanding of cirrhosis pathophysiology, clinical presentation, and disease progression. The critical finding of this analysis is that relying exclusively on Pitta-focused frameworks leads to suboptimal patient care and incomplete disease management. The reductionist approach of treating all liver disorders as simple Pitta imbalances fails to address the complex, multisystem nature of advanced liver disease and may actually hinder recovery in chronic cases. A tridoshic approach, firmly rooted in classical textual authority and supported by modern hepatological knowledge, provides a more comprehensive and effective framework for understanding and managing cirrhosis. This approach recognizes that while liver disease may begin with Pitta predominance, chronic conditions inevitably involve all three doshas, requiring sophisticated, individualized treatment strategies that address inflammation, fibrosis, metabolic dysfunction, and systemic complications simultaneously. The integration of classical Ayurvedic wisdom with contemporary medical science offers significant potential for improving patient outcomes in liver disease. By honoring the strengths of both systems—modern medicine's precision in diagnosis and acute management, and Ayurveda's holistic, individualized approach to chronic disease—we can develop more effective, comprehensive treatment strategies. This review calls for increased research into tridoshic management approaches, better integration of Ayurvedic principles with modern hepatology, and the development of evidence-based protocols that combine the best of both medical traditions. Only through such integration can we achieve truly optimal care for patients suffering from this complex and challenging condition. The implications extend beyond cirrhosis management to the broader field of integrative medicine. This analysis demonstrates how careful correlation of traditional medical systems with modern scientific understanding can yield valuable insights and improved therapeutic approaches. It serves as a model for similar investigations in other disease areas where traditional knowledge may complement and enhance contemporary medical practice. Ultimately, the goal is not to replace modern medical care but to enhance it through the incorporation of time-tested traditional approaches that address aspects of health and healing that may be overlooked in purely biomedical models. The tridoshic understanding of cirrhosis represents one such enhancement, offering hope for better outcomes and improved quality of life for patients facing this serious condition. Compliance with ethical standards Disclosure of conflict of interest This research was conducted as part of the authors’ employment at Sukhayu Ayurved Hospital, Jaipur. The institution had no role in study design, analysis, interpretation, or publication decisions. The authors declare no other conflicts of interest. References [1] Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838-851. World Journal of Advanced Research and Reviews, 2025, 27(03), 596–603 603 [2] Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Elsevier Saunders; 2015. Chapter 18. [3] Goldman L, Schafer AI. Goldman's Cecil Medicine. 24th ed. Elsevier Saunders; 2012. Section 150. [4] Agnivesha. Charaka Samhita, Chikitsa Sthana 16.62–72, 16.84–105. (Ed. & Trans. P.V. Sharma, Chaukhambha Orientalia, 2016). [5] Vagbhata. Ashtanga Hridaya, Nidana Sthana 13.1–18; Chikitsa Sthana 13.1–13 (Ed. K.R. Srikantha Murthy, Krishnadas Academy, 2012). [6] Madhava Nidana, Chapter 10 (Kamala Nidana). (Ed. K.R. Srikantha Murthy, Chaukhambha, 2013). [7] Sharma RK, Dash B. Agnivesa's Charaka Samhita, Text with English Translation & Critical Exposition, Chikitsa Sthana 16.95–105. Chowkhamba Sanskrit Series, 2015. [8] Sushruta Samhita, Nidana Sthana 10.16–19; Chikitsa Sthana 32.1–32. (Ed. Ambikadutta Shastri, Chaukhambha Sanskrit Sansthan, 2012). [9] Sushruta Samhita, Chikitsa Sthana 32.14–19. [10] Pandey AK, et al. Management of Kamala (infective hepatitis) with herbal formulation. J Res Ayurveda. 2014;35(1):97-101. [11] Tripathi B, editor. Astanga Hridaya with commentaries Sarvangasundara and Ayurvedarasayana. Sutra Sthana 12.21–22. Chaukhamba Sanskrit Series, 2007.